Inhaled Gaseous Nitric Oxide (gNO) Antimicrobial Treatment of Difficult Bacterial and Viral Lung (COVID-19) Infections
Clinical trial NCT03331445 · TERMINATED
Trial details
- NCT number
- NCT03331445
- Sponsor
- Chris Miller
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-24
- Primary completion
- 2021-06-30
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.